Sign in Subscribe
Drugs

Advances in Gastroenterology Research: New Insights into Colorectal Cancer Metastasis

Strategic Insights

— 2 min read

Researchers from Japan, the Netherlands, and South Korea have made significant contributions to the field of gastroenterology, shedding light on the complexities of colorectal cancer metastasis. The studies investigated various molecular mechanisms and therapeutic strategies to improve treatment outcomes for patients with liver metastases. The findings of these studies have far-reaching implications for the development of novel treatments and the understanding of disease progression.

Key Takeaways:

  • Study 1: The prognostic factors for patients with resected liver metastases from colorectal cancer were investigated, revealing that the number of metastases, Fas/CD95 expression, and postoperative carcinoembryonic antigen doubling time (CEADT) were significant indicators of survival.
  • Study 2: The removal of a primary colorectal tumor resulted in an increase in metabolic activity in its liver metastasis, indicating that the primary tumor suppressed angiogenesis in its distant metastasis, and that removal of the primary lesion caused a flare-up in vessel neoformation.
  • Study 3: The application of cDNA of LK68 encoding apolipoprotein(a) kringles IV-9, IV-10, and V as a gene therapy treatment was evaluated, showing that LK68-expressing liver metastases were restricted to smaller sizes and displayed decreased microvessel density and increased tumor cell apoptosis.
  • H. Onodera and colleagues used immunohistochemical methods to assess Fas/CD95 expression, microvessel density, and proliferating cell nuclear antigen (PCNA) proliferative activity in patients with resected liver metastases.
  • C.F.J.M. Peeters and colleagues found that removal of a primary colorectal tumor resulted in an increase in metabolic activity in its liver metastasis, and that concomitantly, levels of angiostatin and endostatin in urine and plasma dropped.
  • H.K. Yu and colleagues utilized a murine colorectal cancer cell line to evaluate the application of cDNA of LK68 encoding apolipoprotein(a) kringles IV-9, IV-10, and V as a possible candidate for gene therapy treatment of liver metastasis.

Statistics:

  • The study of 85 patients with resected liver metastases from colorectal cancer found that the number of metastases, Fas/CD95 expression, and postoperative CEADT were significant prognostic indicators.
  • The number of metastases and CEADT correlated with postoperative CEADT (p=0.039), number of metastases (p=0.018), and survival (p=0.023) in Study 1.
  • The study using cDNA of LK68 encoding apolipoprotein(a) kringles IV-9, IV-10, and V found that substantial suppression of liver metastasis and prolonged survival were observed in mice bearing LK68-expressing CT26 cells, compared with controls.
  • The data from the study using cDNA of LK68 encoding apolipoprotein(a) kringles IV-9, IV-10, and V indicated that LK68-expressing liver metastases were restricted to smaller sizes and displayed decreased microvessel density and increased tumor cell apoptosis.

Sources:

  • Onodera, H., et al. Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Int J Colorectal Dis, 2005;20(6):477-484.
  • Peeters, C.F.J.M., et al. Decrease in circulating anti-angiogenic factors (Angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery, 2005;137(2):246-249.
  • Yu, H.K., et al. Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(A) kringles. Cancer Res, 2004;64(19):7092-7098.

Read more